NDC 73309-137 - Clopidogrel Bisulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-137
- Package NDCs from labels
- 73309-137-01
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2020-05-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clopidogrel Bisulfate - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2020-05-25 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-137-01 | Clopidogrel Bisulfate | 1 kg in 1 JAR | POWDER | 1 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clopidogrel | CLOPIDOGREL BISULFATE | Westminster Pharmaceuticals, LLC | bb3b5e96-e629-4db5-8ad5-40c17c6dae18 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 669f0bc6-f173-484d-8efe-c006683b25d1 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 2969deac-274b-4042-9c90-9522e62a979d | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals Inc. | c9928956-bb7b-4ec2-bc38-d3c9c4199cae | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 3e2539c1-a6ad-4d60-944c-c2e7aa70ce45 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL | Redpharm Drug | 55731d95-0c99-ff61-e063-6394a90a1ab5 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | e5ee3807-5c9d-4b65-b188-4159a0fb1c85 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Ascend Laboratories, LLC | db1161c9-6efd-4361-a766-6a37c241ccee | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | Cardinal Health 107, LLC | c03a895c-2d74-4d7f-891f-b752ce409b68 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals, Inc. | e51d4bcc-01df-409d-9179-45e6536ac25b | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | Legacy Pharmaceutical Packaging, LLC | 53de10a5-dbd0-413d-90e5-00a1920ec391 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 553b4938-4462-4aeb-e054-00144ff88e88 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 55530ff3-5ce4-120f-e054-00144ff8d46c | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | 8406b8e3-e203-402f-8858-2748119e2351 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | AvPAK | 94a5cdc4-e063-1d46-e053-2995a90a7e15 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Novadoz Pharmaceuticals LLC | 1447a095-c663-4f05-91d4-f09bfc0c3d42 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Quallent Pharmaceuticals Health LLC | d072b6ea-2bb4-8965-918e-23f9080efcb0 | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Quallent Pharmaceuticals Health LLC | 333c7992-d481-b7d4-404f-9a49c85b6331 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | Apotex Corp. | edae8df1-caf9-ff72-1304-5ae8b355f8e7 | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
| Clopidogrel | CLOPIDOGREL BISULFATE | Major Pharmaceuticals | 4cd07a3c-9673-4aa0-b76a-d79df2399ee1 | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | 08I79HTP27 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.